HER2-NEGATIVE
Clinical trials for HER2-NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new HER2-NEGATIVE trials appear
Sign up with your email to follow new studies for HER2-NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat stomach cancer: experimental drug combo enters phase 2
Disease control Recruiting nowThis study tests a new drug called denikitug, either alone or with other treatments, for people with advanced HER2-negative stomach, gastroesophageal junction, or esophageal cancer that has spread or come back. About 120 participants will be randomly assigned to different treatme…
Matched conditions: HER2-NEGATIVE
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
New hope for hard-to-treat stomach cancer: combo therapy trial launches
Disease control Recruiting nowThis study tests whether a new drug combination (iparomlimab and tuvonralimab, called QL1706) plus chemotherapy can help people with a specific type of advanced stomach cancer that cannot be removed by surgery or has spread. The cancer must be HER2-negative and have low PD-L1 lev…
Matched conditions: HER2-NEGATIVE
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated May 20, 2026 11:54 UTC